Safe Lentiviral Vectors for Targeted Delivery of Multiple Therapeutic Molecules
Country:
US
Docket No:
436313-002417
Publication Number:
10,548,914
Patent Expiry:
10/19/2029
Claims Scope:
Patent issued February 4, 2020.
A lentiviral vector transfer system. This application has the earliest priority date for the AGT non-integrating viral vector system.
–
System and composition to a self-inactivating transfer vector free of wPRE;
multiple gene units each operably linked to a regulatory sequence;
a mammalian insulator sequence; and
a helper construct lacking a 5’ LTR and replaced with a heterologous promoter, further having a non-functional envelope protein and a non-functional packaging sequence.